Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Winter Olympics Test China's 'Zero COVID' Limits, Treatment Constraints

Drug Treatments Still Limited As Torch Arrives

Executive Summary

Amid China’s increasingly inward-looking and dual circulation economic policies, the Beijing Winter Olympics provide rare insight into policymakers’ handling of a global event.

You may also be interested in...



Olympics Foreshadow Beijing's Intention To Follow Own Policy Path?

The Beijing Winter Olympics highlight a changing China that is becoming more confident and confrontational in its policies, although a willingness to challenge international rules could potentially stall the further introductions of novel vaccines and treatments at a critical juncture of the pandemic.

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.

China Coronavirus Approvals: Fast, Free And Fine?

A lack of Emergency Use Authorization potentially jeopardizes China’s efforts to fight the deadly virus outbreak, says a regulatory veteran.

Topics

Related Companies

UsernamePublicRestriction

Register

SC145771

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel